An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Treatment Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.
Platform Reaction and Content Removal
According to the social media company, the service has taken down problematic content and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the service secure and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Research also found groups with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or administering at residence.
Within minutes of entering one community, a seller posted contact information, where most purchases occur. The seller provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.
Product Information and Pricing
Within these communities, messages show black plastic parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has already encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose users to possibly significant health risks”.
